{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:55:47Z","timestamp":1788306947537,"version":"build-2803163510"},"reference-count":140,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Medicine and Pharmacy Carol Davila, Bucharest"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Pituitary neuroendocrine tumors (PitNETs) are slow-growing neoplasms with various clinical presentations, often leading to diagnostic challenges. While neuroimaging assessment and histopathological evaluation remain the gold standard for diagnosis, emerging research highlights the potential of liquid biopsy, mainly through the analysis of circulating non-coding RNAs (ncRNAs), as a promising diagnostic and prognostic tool. Recent studies have demonstrated distinct expression profiles in different types and subtypes of tumors, with implications in assessing tumor aggressiveness and predicting treatment response. The current article summarizes data about potential biofluid markers implicated in PitNET development, mainly circulating tumor DNA (ctDNA), cell-free RNAs (cfRNA), circulating tumor cells (CTCs), and exosomes. Many studies on genetic and molecular markers in PitNET tissue samples provide exciting information about tumor biology, but to date, specific studies on liquid biopsy biomarkers are still few. Over the past years, a certain understanding of the mechanisms involved in pituitary tumorigenesis has been gained, including the landscape of genomic alterations, changes in epigenetic profile, crucial molecules involved in specific signaling pathways, and non-coding RNA molecules with critical roles in malignant transformation. Genetic and molecular characterization of the PitNETs could help distinguish between functional and non-functional PitNETs, different types and subtypes of pituitary tumors, and invasive and non-invasive forms. Further studies are required to identify and validate innovative biomarkers or therapeutic targets for treating PitNET. Integrating liquid biopsy into clinical workflows could revolutionize the management of pituitary adenomas, enabling more personalized and less invasive diagnostic and therapeutic strategies.<\/jats:p>","DOI":"10.3390\/ijms26094058","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T04:08:24Z","timestamp":1745554104000},"page":"4058","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Liquid Biopsy in Pituitary Neuroendocrine Tumors\u2014Potential Biomarkers for Diagnosis, Prognosis, and Therapy"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6788-5833","authenticated-orcid":false,"given":"Ligia Gabriela","family":"Tataranu","sequence":"first","affiliation":[{"name":"Neurosurgical Department, Carol Davila University of Medicine and Pharmacy, 020022 Bucharest, Romania"},{"name":"Neurosurgical Department, Bagdasar-Arseni Clinical Emergency Hospital, 041915 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Dai, C., Kang, J., Liu, X., Yao, Y., Wang, H., and Wang, R. (2021). How to Classify and Define Pituitary Tumors: Recent Advances and Current Controversies. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.604644"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41574-021-00550-w","article-title":"Aggressive Pituitary Tumours and Pituitary Carcinomas","volume":"17","author":"Raverot","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Yang, Q., and Li, X. (2019). Molecular Network Basis of Invasive Pituitary Adenoma: A Review. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00007"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","article-title":"A New Prognostic Clinicopathological Classification of Pituitary Adenomas: A Multicentric Case-Control Study of 410 Patients with 8 Years Post-Operative Follow-Up","volume":"126","author":"Trouillas","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European Society of Endocrinology Clinical Practice Guidelines for the Management of Aggressive Pituitary Tumours and Carcinomas","volume":"178","author":"Raverot","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and Definitions for Research on Epithelial-Mesenchymal Transition","volume":"21","author":"Yang","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nec.2019.05.001","article-title":"Molecular Biology of Pituitary Adenomas","volume":"30","author":"Faltermeier","year":"2019","journal-title":"Neurosurg. Clin. N. Am."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.endinu.2017.05.009","article-title":"Clinically Non-Functioning Pituitary Adenomas: Pathogenic, Diagnostic and Therapeutic Aspects","volume":"64","author":"Mercado","year":"2017","journal-title":"Endocrinol. Diabetes Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrendo.2014.64","article-title":"Aggressive Pituitary Adenomas--Diagnosis and Emerging Treatments","volume":"10","author":"Rotondo","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO Classification of Pituitary Tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Trouillas, J., Jaffrain-Rea, M.L., Vasiljevic, A., Raverot, G., Roncaroli, F., and Villa, C. (2020). How to Classify the Pituitary Neuroendocrine Tumors (PitNET)s in 2020. Cancers, 12.","DOI":"10.3390\/cancers12020514"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00428-019-02655-0","article-title":"A Standardised Diagnostic Approach to Pituitary Neuroendocrine Tumours (PitNETs): A European Pituitary Pathology Group (EPPG) Proposal","volume":"475","author":"Villa","year":"2019","journal-title":"Virchows Arch."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1158\/2159-8290.CD-20-1311","article-title":"Liquid Biopsy: From Discovery to Clinical Application","volume":"11","author":"Pantel","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101716","DOI":"10.1016\/j.tranon.2023.101716","article-title":"Liquid Biopsies: Emerging Role and Clinical Applications in Solid Tumours","volume":"35","author":"Sisodiya","year":"2023","journal-title":"Transl. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/1535-7163.MCT-22-0087","article-title":"Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles","volume":"21","author":"Corvigno","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19336918.2024.2395807","article-title":"Liquid Biopsy: Paving a New Avenue for Cancer Research","volume":"18","author":"Kurma","year":"2024","journal-title":"Cell Adhes. Migr."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hua, G., Yanjiao, H., Qian, L., Jichao, W., and Yazhuo, Z. (2018). Detection of Circulating Tumor Cells in Patients with Pituitary Tumors. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4162-7"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gossing, W., Frohme, M., and Radke, L. (2020). Biomarkers for Liquid Biopsies of Pituitary Neuroendocrine Tumors. Biomedicines, 8.","DOI":"10.3390\/biomedicines8060148"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"de Miranda, F.S., Barauna, V.G., Dos Santos, L., Costa, G., Vassallo, P.F., and Campos, L.C.G. (2021). Properties and Application of Cell-Free DNA as a Clinical Biomarker. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179110"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1007\/s00018-016-2370-3","article-title":"A Historical and Evolutionary Perspective on the Biological Significance of Circulating DNA and Extracellular Vesicles","volume":"73","author":"Aucamp","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bronkhorst, A.J., Ungerer, V., and Holdenrieder, S. (2019). The Emerging Role of Cell-Free DNA as a Molecular Marker for Cancer Management. Biomol. Detect. Quantif., 17.","DOI":"10.1016\/j.bdq.2019.100087"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor Biomarkers for Diagnosis, Prognosis and Targeted Therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Megnis, K., Peculis, R., Rovite, V., Laksa, P., Niedra, H., Balcere, I., Caune, O., Breiksa, A., Nazarovs, J., and Stukens, J. (2019). Evaluation of the Possibility to Detect Circulating Tumor DNA From Pituitary Adenoma. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00615"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11910-018-0820-z","article-title":"Liquid Biopsy in Primary Brain Tumors: Looking for Stardust!","volume":"18","author":"Fontanilles","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-022-01710-w","article-title":"Circulating Tumor Nucleic Acids: Biology, Release Mechanisms, and Clinical Relevance","volume":"22","author":"Stejskal","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11154-022-09777-y","article-title":"The Hallmarks of Cancer\u2026 in Pituitary Tumors?","volume":"24","author":"Kerbel","year":"2023","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chang, M., Yang, C., Bao, X., and Wang, R. (2020). Genetic and Epigenetic Causes of Pituitary Adenomas. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.596554"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000514862","article-title":"Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior","volume":"112","author":"Spada","year":"2022","journal-title":"Neuroendocrinology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Vamvoukaki, R., Chrysoulaki, M., Betsi, G., and Xekouki, P. (2023). Pituitary Tumorigenesis-Implications for Management. Medicina, 59.","DOI":"10.3390\/medicina59040812"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Peculis, R., Niedra, H., and Rovite, V. (2021). Large Scale Molecular Studies of Pituitary Neuroendocrine Tumors: Novel Markers, Mechanisms and Translational Perspectives. Cancers, 13.","DOI":"10.3390\/cancers13061395"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ajhg.2017.03.011","article-title":"Germline Mutations in CDH23, Encoding Cadherin-Related 23, Are Associated with Both Familial and Sporadic Pituitary Adenomas","volume":"100","author":"Zhang","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"ref_32","first-page":"3276","article-title":"Impact of SLC20A1 on the Wnt\/\u0392-catenin Signaling Pathway in Somatotroph Adenomas","volume":"20","author":"Li","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"144456","DOI":"10.1016\/j.gene.2020.144456","article-title":"The Absence of PRDM2 Involved the Tumorigenesis of Somatotroph Adenomas through Regulating C-Myc","volume":"737","author":"Wei","year":"2020","journal-title":"Gene"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/jcmm.13440","article-title":"Association between Dopamine and Somatostatin Receptor Expression and Pharmacological Response to Somatostatin Analogues in Acromegaly","volume":"22","author":"Dios","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Islam, M.T., Chen, F., and Chen, H. (2021). The Oncogenic Role of Ubiquitin Specific Peptidase (USP8) and Its Signaling Pathways Targeting for Cancer Therapeutics. Arch. Biochem. Biophys., 701.","DOI":"10.1016\/j.abb.2021.108811"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1530\/EC-20-0035","article-title":"SST5 Expression and USP8 Mutation in Functioning and Silent Corticotroph Pituitary Tumors","volume":"9","author":"Castellnou","year":"2020","journal-title":"Endocr. Connect."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1038\/s41467-018-05275-5","article-title":"Identification of Recurrent USP48 and BRAF Mutations in Cushing\u2019s Disease","volume":"9","author":"Chen","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s40478-022-01437-1","article-title":"TP53 Mutations in Functional Corticotroph Tumors Are Linked to Invasion and Worse Clinical Outcome","volume":"10","author":"Simon","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/s41467-020-16052-8","article-title":"Somatic SF3B1 Hotspot Mutation in Prolactinomas","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mce.2010.03.019","article-title":"HMGA2: A Pituitary Tumour Subtype-Specific Oncogene?","volume":"326","author":"Fedele","year":"2010","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.mce.2019.04.010","article-title":"Differential Expression of HMGA1 and HMGA2 in Pituitary Neuroendocrine Tumors","volume":"490","author":"Portovedo","year":"2019","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1590\/S0100-879X2012007500115","article-title":"Mutation and Genomic Amplification of the PIK3CA Proto-Oncogene in Pituitary Adenomas","volume":"45","author":"Murat","year":"2012","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1677\/ERC-08-0167","article-title":"Frequent Mutations and Amplifications of the PIK3CA Gene in Pituitary Tumors","volume":"16","author":"Lin","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s40478-020-01067-5","article-title":"Chromosomal Instability in the Prediction of Pituitary Neuroendocrine Tumors Prognosis","volume":"8","author":"Lasolle","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"M\u00f8ller, M.W., Nortvig, M.J., Andersen, M.S., and Poulsen, F.R. (2025). DNA Methylation in Pituitary Adenomas: A Scoping Review. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020531"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/neuonc\/noac050","article-title":"Detection of Tumor-Specific DNA Methylation Markers in the Blood of Patients with Pituitary Neuroendocrine Tumors","volume":"24","author":"Herrgott","year":"2022","journal-title":"Neuro Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.12659\/MSM.910608","article-title":"Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas","volume":"24","author":"Ma","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1677\/ERC-09-0008","article-title":"Loss of Neuronatin Expression Is Associated with Promoter Hypermethylation in Pituitary Adenoma","volume":"16","author":"Revill","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/modpathol.3800965","article-title":"Tumor-Specific Downregulation and Methylation of the CDH13 (H-Cadherin) and CDH1 (E-Cadherin) Genes Correlate with Aggressiveness of Human Pituitary Adenomas","volume":"20","author":"Qian","year":"2007","journal-title":"Mod. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/sj.onc.1205195","article-title":"Preferential Loss of Death Associated Protein Kinase Expression in Invasive Pituitary Tumours Is Associated with Either CpG Island Methylation or Homozygous Deletion","volume":"21","author":"Simpson","year":"2002","journal-title":"Oncogene"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00401-024-02836-5","article-title":"Genome-Wide Methylation Profiling Differentiates Benign from Aggressive and Metastatic Pituitary Neuroendocrine Tumors","volume":"148","author":"Jotanovic","year":"2024","journal-title":"Acta Neuropathol."},{"key":"ref_52","first-page":"1262","article-title":"Loss of Expression of GADD45 Gamma, a Growth Inhibitory Gene, in Human Pituitary Adenomas: Implications for Tumorigenesis","volume":"87","author":"Zhang","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2010.04.026","article-title":"Identification and Consequences of Galectin-3 Expression in Pituitary Tumors","volume":"326","author":"Righi","year":"2010","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/labinvest.3700248","article-title":"Inactivation of RASSF1A Tumor Suppressor Gene by Aberrant Promoter Hypermethylation in Human Pituitary Adenomas","volume":"85","author":"Qian","year":"2005","journal-title":"Lab. Investig."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e3346","DOI":"10.1210\/clinem\/dgab387","article-title":"Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease","volume":"106","author":"Araki","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1507\/endocrj.K08E-082","article-title":"Epigenetic Control in Pituitary Tumors","volume":"55","author":"Ezzat","year":"2008","journal-title":"Endocr. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/path.833","article-title":"CDKN2A\/P16 Inactivation Is Related to Pituitary Adenoma Type and Size","volume":"193","author":"Seemann","year":"2001","journal-title":"J. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Pease, M., Ling, C., Mack, W.J., Wang, K., and Zada, G. (2013). The Role of Epigenetic Modification in Tumorigenesis and Progression of Pituitary Adenomas: A Systematic Review of the Literature. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0082619"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-014-1479-1","article-title":"Identification of a Subtype-Specific ENC1 Gene Related to Invasiveness in Human Pituitary Null Cell Adenoma and Oncocytomas","volume":"119","author":"Feng","year":"2014","journal-title":"J. Neurooncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.18632\/aging.102751","article-title":"Integrated Analysis of DNA Methylation and mRNA Expression Profiles to Identify Key Genes Involved in the Regrowth of Clinically Non-Functioning Pituitary Adenoma","volume":"12","author":"Cheng","year":"2020","journal-title":"Aging"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/227561a0","article-title":"Central Dogma of Molecular Biology","volume":"227","author":"Crick","year":"1970","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41422-024-00975-8","article-title":"Coding, or Non-Coding, That Is the Question","volume":"34","author":"Poliseno","year":"2024","journal-title":"Cell Res."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Wu, W., Cao, L., Jia, Y., Xiao, Y., Zhang, X., and Gui, S. (2022). Emerging Roles of miRNA, lncRNA, circRNA, and Their Cross-Talk in Pituitary Adenoma. Cells, 11.","DOI":"10.3390\/cells11182920"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Donati, S., Aurilia, C., Palmini, G., Miglietta, F., Falsetti, I., Iantomasi, T., and Brandi, M.L. (2021). MicroRNAs as Potential Biomarkers in Pituitary Adenomas. Noncoding RNA, 7.","DOI":"10.3390\/ncrna7030055"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Toden, S., Zumwalt, T.J., and Goel, A. (2021). Non-Coding RNAs and Potential Therapeutic Targeting in Cancer. Biochim. Biophys. Acta Rev. Cancer, 1875.","DOI":"10.1016\/j.bbcan.2020.188491"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Zhang, C., Sun, C., Zhao, Y., Wang, Q., Guo, J., Ye, B., and Yu, G. (2022). Overview of MicroRNAs as Diagnostic and Prognostic Biomarkers for High-Incidence Cancers in 2021. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911389"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/jpet.121.000896","article-title":"Circulating microRNAs as Reliable Tumor Biomarkers: Opportunities and Challenges Facing Clinical Application","volume":"384","author":"Gouhar","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000079045","article-title":"Pituitary Tumour Clonality Revisited","volume":"32","author":"Clayton","year":"2004","journal-title":"Front. Horm. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jcp.20282","article-title":"miR-15a and miR-16-1 down-Regulation in Pituitary Adenomas","volume":"204","author":"Bottoni","year":"2005","journal-title":"J. Cell Physiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s13760-023-02354-3","article-title":"The Potential Link between Acromegaly and Risk of Acute Ischemic Stroke in Patients with Pituitary Adenoma: A New Perspective","volume":"124","author":"Alnaaim","year":"2024","journal-title":"Acta Neurol. Belg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2019.07.013","article-title":"Exosomal Hsa-miR-21-5p Derived from Growth Hormone-Secreting Pituitary Adenoma Promotes Abnormal Bone Formation in Acromegaly","volume":"215","author":"Xiong","year":"2020","journal-title":"Transl. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/EJE-17-0772","article-title":"Effects of Active Acromegaly on Bone mRNA and microRNA Expression Patterns","volume":"178","author":"Belaya","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.3906\/sag-2010-245","article-title":"Circulating miR-29c-3p Is Downregulated in Patients with Acromegaly","volume":"51","author":"Korkmaz","year":"2021","journal-title":"Turk. J. Med. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"8516858","DOI":"10.1155\/2019\/8516858","article-title":"Identification of Serum miRNA-423-5p Expression Signature in Somatotroph Adenomas","volume":"2019","author":"Zhao","year":"2019","journal-title":"Int. J. Endocrinol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1002\/ijc.33268","article-title":"miR-34a Is Upregulated in AIP-Mutated Somatotropinomas and Promotes Octreotide Resistance","volume":"147","author":"Bogner","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"E373","DOI":"10.1210\/jc.2009-2556","article-title":"Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study","volume":"95","author":"Daly","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1210\/jc.2018-02544","article-title":"MiR-137\u2019s Tumor Suppression on Prolactinomas by Targeting MITF and Modulating Wnt Signaling Pathway","volume":"104","author":"Lei","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10565-020-09570-0","article-title":"Up-Regulation of the Expressions of MiR-149-5p and MiR-99a-3p in Exosome Inhibits the Progress of Pituitary Adenomas","volume":"37","author":"Zhao","year":"2021","journal-title":"Cell Biol. Toxicol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12935-024-03529-5","article-title":"MicroRNA Networks in Prolactinoma Tumorigenesis: A Scoping Review","volume":"24","author":"Rad","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"111033","DOI":"10.1016\/j.mce.2020.111033","article-title":"The Long Noncoding RNA-H19\/miRNA-93a\/ATG7 Axis Regulates the Sensitivity of Pituitary Adenomas to Dopamine Agonists","volume":"518","author":"Wu","year":"2020","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Belaya, Z., Khandaeva, P., Nonn, L., Nikitin, A., Solodovnikov, A., Sitkin, I., Grigoriev, A., Pikunov, M., Lapshina, A., and Rozhinskaya, L. (2020). Circulating Plasma microRNA to Differentiate Cushing\u2019s Disease From Ectopic ACTH Syndrome. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00331"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1111\/jcmm.14297","article-title":"TSP-1 Is Downregulated and Inversely Correlates with miR-449c Expression in Cushing\u2019s Disease","volume":"23","author":"Ren","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s12020-017-1506-z","article-title":"Analysis of Circulating Extracellular Vesicle-Associated microRNAs in Cortisol-Producing Adrenocortical Tumors","volume":"59","author":"Perge","year":"2018","journal-title":"Endocrine"},{"key":"ref_84","first-page":"1655","article-title":"Bioinformatic Analysis of Gene Expression Profiles of Pituitary Gonadotroph Adenomas","volume":"15","author":"Hou","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Yang, J.T., Lee, I.N., Huang, C., Huang, H.C., Wu, Y.P., Chong, Z.Y., and Chen, J.C. (2023). ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24097703"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"R545","DOI":"10.1530\/ERC-19-0083","article-title":"How and When to Use Temozolomide to Treat Aggressive Pituitary Tumours","volume":"26","author":"Whitelaw","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Beylerli, O., Beeraka, N.M., Gareev, I., Pavlov, V., Yang, G., Liang, Y., and Aliev, G. (2020). MiRNAs as Noninvasive Biomarkers and Therapeutic Agents of Pituitary Adenomas. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197287"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1210\/jc.2018-02479","article-title":"Comprehensive Analysis of Circulating miRNAs in the Plasma of Patients With Pituitary Adenomas","volume":"104","author":"Darvasi","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3730657","DOI":"10.1155\/2020\/3730657","article-title":"The Search of miRNA Related to Invasive Growth of Nonfunctioning Gonadotropic Pituitary Tumors","volume":"2020","author":"Boresowicz","year":"2020","journal-title":"Int. J. Endocrinol."},{"key":"ref_90","first-page":"1557","article-title":"miR-137 Functions as a Tumor Suppressor Gene in Pituitary Adenoma by Targeting AKT2","volume":"12","author":"Duan","year":"2019","journal-title":"Int. J.Clin. Exp. Pathol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1210\/en.2007-0542","article-title":"Wnt Pathway Inhibitors Are Strongly Down-Regulated in Pituitary Tumors","volume":"149","author":"Elston","year":"2008","journal-title":"Endocrinology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.mce.2018.03.005","article-title":"Aberrant Expression of the sFRP and WIF1 Genes in Invasive Non-Functioning Pituitary Adenomas","volume":"474","author":"Song","year":"2018","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1210\/jc.2018-01851","article-title":"circOMA1-Mediated miR-145-5p Suppresses Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting TPT1","volume":"104","author":"Du","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Gilyazova, I., Asadullina, D., Kagirova, E., Sikka, R., Mustafin, A., Ivanova, E., Bakhtiyarova, K., Gilyazova, G., Gupta, S., and Khusnutdinova, E. (2023). MiRNA-146a\u2014A Key Player in Immunity and Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612767"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/1873-3468.14948","article-title":"Micromanaging the Neuroendocrine System\u2014A Review on miR-7 and the Other Physiologically Relevant miRNAs in the Hypothalamic-Pituitary Axis","volume":"598","author":"Zacharjasz","year":"2024","journal-title":"FEBS Lett."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Niedra, H., Peculis, R., Litvina, H.D., Megnis, K., Mandrika, I., Balcere, I., Romanovs, M., Steina, L., Stukens, J., and Breiksa, A. (2022). Genome Wide Analysis of Circulating miRNAs in Growth Hormone Secreting Pituitary Neuroendocrine Tumor Patients\u2019 Plasma. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.894317"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Fu, J., Imani, S., Wu, M.Y., and Wu, R.C. (2023). MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential. Cancers, 15.","DOI":"10.20944\/preprints202308.0847.v1"},{"key":"ref_98","first-page":"721","article-title":"The Experimental Study of miRNA in Pituitary Adenomas","volume":"23","author":"Liang","year":"2013","journal-title":"Turk. Neurosurg."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"435171","DOI":"10.1155\/2014\/435171","article-title":"MicroRNAs in Human Pituitary Adenomas","volume":"2014","author":"Li","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"E181","DOI":"10.1210\/jc.2010-0581","article-title":"Down-Regulation of Wee1 Kinase by a Specific Subset of microRNA in Human Sporadic Pituitary Adenomas","volume":"95","author":"Butz","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Mart\u00ednez, A., Fuentes-Fayos, A.C., Fajardo, C., Lamas, C., C\u00e1mara, R., L\u00f3pez-Mu\u00f1oz, B., Aranda, I., Luque, R.M., and Pic\u00f3, A. (2020). Differential Expression of MicroRNAs in Silent and Functioning Corticotroph Tumors. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061838"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/09168451.2019.1591260","article-title":"MicroRNA-543 Promotes Cell Invasion and Impedes Apoptosis in Pituitary Adenoma via Activating the Wnt\/\u03b2-Catenin Pathway by Negative Regulation of Smad7","volume":"83","author":"Shen","year":"2019","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4161\/rna.20481","article-title":"The Hallmarks of Cancer: A Long Non-Coding RNA Point of View","volume":"9","author":"Gutschner","year":"2012","journal-title":"RNA Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s43042-024-00553-y","article-title":"A Brief Review of Noncoding RNA","volume":"25","author":"George","year":"2024","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The Hallmarks of Cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Xing, W., Qi, Z., Huang, C., Zhang, N., Zhang, W., Li, Y., Qiu, M., Fang, Q., and Hui, G. (2019). Genome-Wide Identification of lncRNAs and mRNAs Differentially Expressed in Non-Functioning Pituitary Adenoma and Construction of an lncRNA-mRNA Co-Expression Network. Biol. Open, 8.","DOI":"10.1242\/bio.037127"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11102-011-0340-1","article-title":"Expression of Cell Growth Negative Regulators MEG3 and GADD45\u03b3 Is Lost in Most Sporadic Human Pituitary Adenomas","volume":"15","author":"Mezzomo","year":"2012","journal-title":"Pituitary"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1210\/jc.2007-2633","article-title":"Selective Loss of MEG3 Expression and Intergenic Differentially Methylated Region Hypermethylation in the MEG3\/DLK1 Locus in Human Clinically Nonfunctioning Pituitary Adenomas","volume":"93","author":"Gejman","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1210\/jc.2004-1848","article-title":"Hypermethylation of the Promoter Region Is Associated with the Loss of MEG3 Gene Expression in Human Pituitary Tumors","volume":"90","author":"Zhao","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11102-014-0554-0","article-title":"Expression of the Long Non-Coding RNAs MEG3, HOTAIR, and MALAT-1 in Non-Functioning Pituitary Adenomas and Their Relationship to Tumor Behavior","volume":"18","author":"Li","year":"2015","journal-title":"Pituitary"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijdevneu.2018.03.009","article-title":"Expression of the Long Non-Coding RNA H19 and MALAT-1 in Growth Hormone-Secreting Pituitary Adenomas and Its Relationship to Tumor Behavior","volume":"67","author":"Lu","year":"2018","journal-title":"Int. J. Dev. Neurosci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1038\/s41467-018-06853-3","article-title":"Inhibition of mTORC1 by lncRNA H19 via Disrupting 4E-BP1\/Raptor Interaction in Pituitary Tumours","volume":"9","author":"Wu","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1210\/jc.2019-00536","article-title":"Exosome-Transmitted lncRNA H19 Inhibits the Growth of Pituitary Adenoma","volume":"104","author":"Zhang","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00109-019-01789-7","article-title":"RPSAP52 lncRNA Is Overexpressed in Pituitary Tumors and Promotes Cell Proliferation by Acting as miRNA Sponge for HMGA Proteins","volume":"97","author":"Mussnich","year":"2019","journal-title":"J. Mol. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41419-019-1694-y","article-title":"FOXP1-Induced lncRNA CLRN1-AS1 Acts as a Tumor Suppressor in Pituitary Prolactinoma by Repressing the Autophagy via Inactivating Wnt\/\u03b2-Catenin Signaling Pathway","volume":"10","author":"Wang","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"154573","DOI":"10.1016\/j.prp.2023.154573","article-title":"Dysregulation of PVT1 and NEAT1 lncRNAs in Pituitary Adenomas","volume":"248","author":"Abbasi","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"ref_117","first-page":"245","article-title":"Long Noncoding RNA CCAT2 Is Activated by E2F1 and Exerts Oncogenic Properties by Interacting with PTTG1 in Pituitary Adenomas","volume":"8","author":"Fu","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Sanchez, A., Lhuillier, J., Grosjean, G., Ayadi, L., and Maenner, S. (2023). The Long Non-Coding RNA ANRIL in Cancers. Cancers, 15.","DOI":"10.3390\/cancers15164160"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ncrna.2021.06.004","article-title":"Differential Non-Coding RNAs Expression Profiles of Invasive and Non-Invasive Pituitary Adenomas","volume":"6","author":"Beylerli","year":"2021","journal-title":"Noncoding RNA Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41419-021-03861-y","article-title":"LncRNA LINC00473 Is Involved in the Progression of Invasive Pituitary Adenoma by Upregulating KMT5A via ceRNA-Mediated miR-502-3p Evasion","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41419-021-03812-7","article-title":"Long Non-Coding RNA TUG1\/microRNA-187-3p\/TESC Axis Modulates Progression of Pituitary Adenoma via Regulating the NF-\u03baB Signaling Pathway","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.prp.2018.09.023","article-title":"Long-Noncoding RNA IFNG-AS1 Exerts Oncogenic Properties by Interacting with Epithelial Splicing Regulatory Protein 2 (ESRP2) in Pituitary Adenomas","volume":"214","author":"Lu","year":"2018","journal-title":"Pathol. Res. Pract."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3892\/or.2017.5739","article-title":"Long Non-Coding RNA C5orf66-AS1 is Downregulated in Pituitary Null Cell Adenomas and Is Associated with Their Invasiveness","volume":"38","author":"Yu","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Butz, H. (2022). Circulating Noncoding RNAs in Pituitary Neuroendocrine Tumors-Two Sides of the Same Coin. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23095122"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","article-title":"The Biogenesis, Functions, and Challenges of Circular RNAs","volume":"71","author":"Li","year":"2018","journal-title":"Mol. Cell"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.molcel.2015.03.027","article-title":"Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed","volume":"58","author":"Stottmeister","year":"2015","journal-title":"Mol. Cell"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainresbull.2020.04.018","article-title":"Comprehensive Circular RNA Profiling Reveals That Hsa_circ_0001368 Is Involved in Growth Hormone-Secreting Pituitary Adenoma Development","volume":"161","author":"Du","year":"2020","journal-title":"Brain Res. Bull."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41388-022-02186-0","article-title":"CircVPS13C Promotes Pituitary Adenoma Growth by Decreasing the Stability of IFITM1 mRNA via Interacting with RRBP1","volume":"41","author":"Zhang","year":"2022","journal-title":"Oncogene"},{"key":"ref_129","first-page":"113","article-title":"A two-circRNA Signature Predicts Tumour Recurrence in Clinical Non-functioning Pituitary Adenoma","volume":"41","author":"Guo","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1016\/j.wneu.2018.06.038","article-title":"Circular RNA In Invasive and Recurrent Clinical Nonfunctioning Pituitary Adenomas: Expression Profiles and Bioinformatic Analysis","volume":"117","author":"Wang","year":"2018","journal-title":"World Neurosurg."},{"key":"ref_131","first-page":"6157","article-title":"CircABCB10 Promotes the Proliferation and Migration of Lung Cancer Cells through Down-Regulating microRNA-217 Expression","volume":"24","author":"Hu","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e16148","DOI":"10.1097\/MD.0000000000016148","article-title":"Differential Circular RNA Expression Profiles of Invasive and Non-Invasive Non-Functioning Pituitary Adenomas: A Microarray Analysis","volume":"98","author":"Hu","year":"2019","journal-title":"Med. Baltim."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Lisiewicz, P., Szelachowska, M., Kr\u0119towski, A.J., and Siewko, K. (2024). The Prospective Roles of Exosomes in Pituitary Tumors. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1482756"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e70009","DOI":"10.1002\/mco2.70009","article-title":"Extracellular Vesicles in Cancers: Mechanisms, Biomarkers, and Therapeutic Strategies","volume":"5","author":"Ma","year":"2024","journal-title":"MedComm"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"168","DOI":"10.24920\/003585","article-title":"Identification of CDK6 and RHOU in Serum Exosome as Biomarkers for the Invasiveness of Non-Functioning Pituitary Adenoma","volume":"34","author":"Yu","year":"2019","journal-title":"Chin. Med. Sci. J."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Lyu, L., Li, H., Chen, C., Yu, Y., Wang, L., Yin, S., Hu, Y., Jiang, S., Ye, F., and Zhou, P. (2021). Exosomal miRNA Profiling Is a Potential Screening Route for Non-Functional Pituitary Adenoma. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.771354"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1007\/s12035-024-04387-y","article-title":"Exosomal AFAP1-AS1 Promotes the Growth, Metastasis, and Glycolysis of Pituitary Adenoma by Inhibiting HuR Degradation","volume":"62","author":"Tang","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/a-2201-8370","article-title":"Exosomal CircMFN2 Enhances the Progression of Pituitary Adenoma via the MiR-146a-3p\/TRAF6\/NF-\u03baB Pathway","volume":"86","author":"Wan","year":"2025","journal-title":"J. Neurol. Surg. A Cent. Eur. Neurosurg."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.2147\/NDT.S339067","article-title":"EMT-Related Markers in Serum Exosomes Are Potential Diagnostic Biomarkers for Invasive Pituitary Adenomas","volume":"17","author":"Chen","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2022.01.014","article-title":"Diagnosis of Invasive Non-Functional Pituitary Adenomas Using Exosomal Biomarkers","volume":"529","author":"Ren","year":"2022","journal-title":"Clin. Chim. Acta"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/9\/4058\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:21:12Z","timestamp":1760030472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/9\/4058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":140,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijms26094058"],"URL":"https:\/\/doi.org\/10.3390\/ijms26094058","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]}}}